Form 4: Beta Bionics CEO Sean Saint Sells Shares for Tax Coverage

CEO Sean Saint sold 16,872 shares of Beta Bionics common stock to satisfy tax withholding obligations related to RSU vesting.

Summary

• Reporting person Sean Saint, President and CEO of Beta Bionics, Inc., sold 16,872 shares of common stock.
• The transaction occurred on June 2, 2026.
• The shares were sold at a weighted average price of $12.6071 per share, with prices ranging from $12.30 to $12.93.
• Following the transaction, the reporting person maintains beneficial ownership of 420,937 shares.
• The sale was executed specifically to cover tax withholding obligations associated with the vesting of restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was purely administrative to cover tax liabilities rather than a discretionary divestment.

Positives

• The sale was non-discretionary, executed solely to satisfy tax obligations related to equity compensation vesting.

Negatives

• Reduction in direct equity stake held by the CEO.

Risks

• None identified; this is a routine administrative transaction.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding purposes are standard corporate practice and generally do not signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation practices where equity awards are settled net of tax.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was for tax compliance purposes.

Key Dates

Keywords

Beta Bionics, BBNX, Insider Trading, Form 4, Executive Compensation, Tax Withholding